Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer

Kerrie Clarke; Russell L Basser; Darryl W Maher; Denis J Morgan; Jonathan Cebon; Richard M Fox; John S Hill; Carole Alt; Jane Bartlett; Howard Geldard; Andrew H Kaye; Michael D Green

Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer

Kerrie Clarke, Russell L Basser, Darryl W Maher, Denis J Morgan, Jonathan Cebon, Richard M Fox, John S Hill, Carole Alt, Jane Bartlett, Howard Geldard, Andrew H Kaye, Michael D Green

Drug Delivery Disposition & Dynamics

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	2181 - 2187
Number of pages	7
Journal	Journal of Clinical Oncology
Publication status	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e8ec503bec17474483daf92e0013babb,

title = "Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer",

author = "Kerrie Clarke and Basser, {Russell L} and Maher, {Darryl W} and Morgan, {Denis J} and Jonathan Cebon and Fox, {Richard M} and Hill, {John S} and Carole Alt and Jane Bartlett and Howard Geldard and Kaye, {Andrew H} and Green, {Michael D}",

year = "1998",

language = "English",

pages = "2181 -- 2187",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer

AU - Clarke, Kerrie

AU - Basser, Russell L

AU - Maher, Darryl W

AU - Morgan, Denis J

AU - Cebon, Jonathan

AU - Fox, Richard M

AU - Hill, John S

AU - Alt, Carole

AU - Bartlett, Jane

AU - Geldard, Howard

AU - Kaye, Andrew H

AU - Green, Michael D

PY - 1998

Y1 - 1998

M3 - Article

SP - 2181

EP - 2187

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

ER -